In clinical trials, the early initiation of HIV treatment (ART) stabilizes the immune system and significantly reduces the risk of developing AIDS-related infections and cancers. This benefit of ART is so profound that researchers increasingly expect that many ART users will live into their senior years. Key to reaping the benefit of ART is achieving […]
The history of HIV/AIDS, PrEP, viral loads, the stigma behind the start of it all and where we need to go from here were some of the talking points touched upon in the last Censored Series of the Spring 2017 semester. The talk was hosted in the Women’s Resource Center, where taboo topics are destigmatized
Conversation on HIV/AIDS reveals lack of understanding among some students Read More »
Participants, within a BC-CfE study cohort of gay, bisexual and other men who have sex with men, describe having to advocate for themselves and educate health care providers on their sexual health needs.
A meta-analysis of studies of brief interventions to reduce HIV risk behaviour in HIV-negative gay men has concluded that there is evidence that such techniques did have a significant impact on the behaviours they were designed to change. It also found evidence that the best way to conduct such interventions was face-to-face, i.e. not via
Behaviour change interventions in HIV prevention: is there still a place for them? Read More »
The latest HIV figures out of NSW point to progress towards the state’s goal of eliminating transmission by 2020. Last year, 317 residents were notified with HIV – the lowest annual count in more than five years – despite a 21 percent jump in the number of tests conducted in public sexual health clinics. It
The number of new HIV diagnoses in gay men attending five key London clinics fell substantially during 2015 and 2016, Valerie Delpech of Public Health England told the British HIV Association (BHIVA) conference in Liverpool yesterday. Epidemiological analysis shows that the phenomenon is real. Diagnoses fell while testing rates dramatically increased, showing that the explanation
Applications are now open for MSFHR’s Reach Awards, a new award program that will provide funding to support the dissemination and uptake of research evidence. The Reach Awards will help teams of health researchers and research users collaboratively plan and implement dissemination activities, adapting messages and mode of delivery in order to reach audiences who
Applications open: MSFHR Reach Awards Read More »
“While we talk about ‘game-changers’ in terms of bio-medical or pharmaceutical solutions, the real game changer is the positive person.” Since the beginning of the HIV epidemic, from the early ’80s to the present day, gay men living with HIV (PLHIV) have been at the forefront of embracing the latest changes to HIV health in
TasP is a ‘game-changer’ for people living with HIV Read More »
BC-CfE research finds HIV cases were averted through the implementation of Treatment as Prevention¨, needle distribution programs and opioid agonist therapy. VANCOUVER, March 31, 2017 /CNW/ – A study by the BC Centre for Excellence in HIV/AIDS (BC-CfE), published in the top-ranking medical journal The Lancet HIV, has found harm reduction and access to HIV
BC-CfE research finds HIV cases were averted through the implementation of Treatment as Prevention¨, needle distribution programs and opioid agonist therapy.
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
